Catalent Pharma Solutions competitors

C-Level Executive with demonstrated leadership skills and proven business results in Pharmaceuticals (Branded and Generics), Sales, Marketing, Operations, Business Development, R&D/Regulatory.I'm a creative problem-solver, with a track record of outstanding results through professional and interpersonal skills including strategic vision, team development, people management, prioritization, motivation, decisiveness and grit.

José E. Almeida is a Brazilian businessman. He has served as the chairman and CEO of Baxter International, Inc. since January 2016. He worked for Tyco Healthcare from 1995 to 2002. He was president of Medical Devices division from October 2006 to June 2011. He served as chairman of the board of directors of Covidien since March 2012 and as the president, chief executive officer and a director since July 2011. He became a director of EMC Corporation on Jan 12, 2015 and resigned on October 30, 2015, due to his election as chairman and CEO of Baxter. In 2015, he worked for The Carlyle Group as an Operating Executive in the Global Healthcare group.

James Clifford Foster is the chairman and chief executive officer of Charles River Laboratories, Inc., an international company that works on the drug discovery and development process. Charles River Laboratories is the world's largest breeder of animals for use in laboratory experimentation.

Jamie Macdonald is Chief Executive Officer of Parexel. He has nearly 25 years of experience in leading global biopharmaceutical services companies. Prior to joining Parexel, Mr. Macdonald served as CEO of INC Research, now known as Syneos Health, from January 2013 through September 2016, where he led the company through a successful Initial Public Offering in 2014. Mr. Macdonald also served as INC’s Chief Operating Officer from July 2011 through December 2012, and previously held several leadership positions in the biopharmaceutical services industry, including Senior Vice President and Head of Global Project Management at Quintiles, now known as IQVIA. Prior to this, he held various senior operational and finance roles at Quintiles. He has previously served on the Board of Directors for the Association of Clinical Research Organizations (ACRO) and as its Chairman in 2015. Mr. Macdonald’s recent experience also includes serving as Chairman of the Board for Certara, a drug development consultancy with solutions spanning discovery, preclinical and clinical drug development, from 2017 to 2018. Mr. Macdonald began his career in the pharmaceutical industry with Syntex Corporation (acquired by Roche Holdings, Inc.). A native of Scotland, he holds a B.A. in Economics from Heriot-Watt University in Edinburgh, Scotland and is a qualified Chartered Management Accountant (ACMA).

Aaron Greenblatt is a Chief Executive Officer at G&W Laboratories Inc. He has worked as Director: Business Dev & Sales at G&W Laboratories Inc, Director:Supply Chain at G&W Laboratories Inc, and Chief Commercial Officer at G&W Laboratories Inc. Aaron studied at University of Maryland.

Anil D'souza is a Chief Executive Officer at TOLMAR and is based in Lincolnshire, Illinois. He has worked as President, Japan & Emerging Markets at HOSPIRA INC; First Lieutenant at Marine Corps Recruiting; and Client Manager at INTERNATIONAL BUSINESS MACHINES CORP. Anil attended Tuck School of Business at Dartmouth between 1998 and 2000, University of Chicago Committee on International Relations between 1989 and 1991, and University of Chicago between 1987 and 1991.

Arpit Patel is an Associate Director, Quality Assurance and Compliance at Aurolife Pharma LLC and Chief Executive Officer & Board Member at CorePharma LLC and is based in Dayton, New Jersey. He has worked as Quality Engineer, Quality Compliance at 29 Consulting LLC - Vascular Therapies, Inc; Quality Assurance Consultant at CorePharma LLC; and Acting Director, Quality Assurance and Compliance at Aurolife Pharma LLC. Arpit attended Fairleigh Dickinson University-Metropolitan Campus between 2007 and 2009; Gujarat University, L M College of Pharmacy; and Telnet between 2002 and 2006.

Ketan is the founder of Tris Pharma. Under his leadership, Tris Pharma has developed many innovative technologies, launched new products, and established itself as a leader among technology-driven pharmaceutical companies. Ketan’s work at Tris has led to many discoveries and inventions. Before founding Tris Pharma, Ketan worked for Capsugel (formerly a division of Pfizer) in sales, marketing and business development for eight years. Prior to Capsugel, he spent approximately six years as a pharmaceutical scientist for three different large pharmaceutical companies. Ketan is a pharmacist by education and holds an MS degree in Pharmaceutical Sciences from the University of Oklahoma.